TVTX FY 2021 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$132M-33.5% YoY

Gross Profit

$128M97.1% margin

Operating Income

-$199M-151.3% margin

Net Income

-$180M-136.6% margin

EPS (Diluted)

$-3.01

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$39M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$777M

Total Liabilities

$475M

Stockholders' Equity

$302M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$132M	$198M	-33.5%
Gross Profit	$128M	$192M	-33.4%
Operating Income	-$199M	-$176M	-13.2%
Net Income	-$180M	-$169M	-6.3%